Prof. Dr. med. Michael Platten

Prof. Dr. med. Michael Platten is a highly accomplished neurologist with over 25 years of experience. He has an impressive educational background, studying human medicine at renowned institutions such as Bonn University, London University, and Harvard Medical School. Prof. Platten's dedication to his field is evident in his numerous achievements, including obtaining a medical practice license and completing a dissertation at the Institute for Neuropathology, University of Bonn. Throughout his career, Prof. Platten has made significant contributions to the field of neurology through his extensive research activities and scientific publications. He has been recognized with several prestigious awards, including the Basic Young Scientist Award from the European Association of Neuro-Oncology and the Helmut Bauer Award for Multiple Sclerosis Research. These accolades highlight his expertise in neuroimmunology and brain tumor immunology. Prof. Platten serves as the Founding Director of the Department of Neurology at the University Hospital Mannheim in Germany. His leadership and specialization in neurology make him a valuable asset to the medical community. Prof. Platten's dedication to advancing the understanding and treatment of neurological conditions, particularly gliomas, is evident in his role as the Leading Investigator of the NOA-16 trial, which focuses on developing an IDH1 vaccine for gliomas. In summary, Prof. Dr. med. Michael Platten's impressive career, extensive experience, and groundbreaking research in neuroimmunology and brain tumor immunology make him a highly respected and sought-after neurologist. His role as the Founding Director of the Department of Neurology at the University Hospital Mannheim further solidifies his position as a leading expert in his field.